In Brief: Organon Teknika
This article was originally published in The Gray Sheet
Executive Summary
Organon Teknika: Grants Toyobo non-exclusive rights to use its nucleic acid amplification technology in Japan "in the fields of infectious disease screening and genetic and cancer testing, with an option to other fields of application." Teknika began selling HIV research kits using its technology in 1994 in Europe and the U.S. The agreement is "one of the first" amplification licenses granted by Organon, and "underlines that it forms an excellent alternative to polymer chain reaction amplification"...